JOURNAL OF BIOMEDICAL SCIENCE

Scope & Guideline

Advancing knowledge in biomedical science for a healthier tomorrow.

Introduction

Explore the comprehensive scope of JOURNAL OF BIOMEDICAL SCIENCE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF BIOMEDICAL SCIENCE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1021-7770
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1993 to 2024
AbbreviationJ BIOMED SCI / J. Biomed. Sci.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Biomedical Science aims to provide a comprehensive platform for the dissemination of cutting-edge research in the field of biomedical science, encompassing a wide range of topics that bridge laboratory research and clinical applications.
  1. Cancer Research and Treatment:
    The journal consistently publishes studies focused on cancer diagnosis, treatment methodologies, and the molecular mechanisms underlying various cancers, contributing significantly to the field of oncology.
  2. Infectious Diseases and Antibiotic Resistance:
    Research on infectious diseases, particularly concerning bacterial resistance mechanisms and case studies related to antibiotic efficacy, is a core focus, highlighting emerging challenges in public health.
  3. Biomedical Education and Training:
    The journal emphasizes educational methodologies in biomedical sciences, including innovative teaching strategies and curriculum development, aiming to enhance the competency and employability of future biomedical scientists.
  4. Clinical Diagnostics and Biomarkers:
    A significant portion of the published works explores diagnostic techniques, biomarker identification, and their clinical relevance, aiding in the advancement of personalized medicine.
  5. Microbiology and Immunology:
    The journal covers extensive research on microbiological studies and immune responses, particularly in the context of chronic infections and autoimmune diseases.
  6. Genetics and Genomic Medicine:
    There is a strong emphasis on genetic studies related to various diseases, including cancer and metabolic disorders, underlining the importance of genetic factors in disease progression and treatment.
The Journal of Biomedical Science has observed a dynamic evolution in its thematic focus, with several emerging areas gaining prominence in recent publications, reflecting current trends and advancements in the biomedical field.
  1. Impact of COVID-19 on Health Sciences:
    There is a significant increase in research related to COVID-19, including its clinical outcomes, diagnostic challenges, and the long-term implications of the pandemic on public health and medical practices.
  2. Integration of Technology in Education:
    Emerging themes in educational techniques, such as gamification and online collaborative learning, indicate a trend towards innovative teaching methods that enhance student engagement and learning outcomes in biomedical sciences.
  3. One Health Approach:
    The One Health concept, which emphasizes the interconnectedness of human, animal, and environmental health, is gaining traction, showcasing the need for interdisciplinary research in addressing global health challenges.
  4. Personalized Medicine and Genomics:
    An increasing focus on genetic variants and their implications for personalized treatment strategies in various diseases is evident, highlighting the relevance of precision medicine in modern healthcare.
  5. Antimicrobial Resistance Studies:
    Research addressing antimicrobial resistance, particularly in the context of chronic infections and treatment strategies, reflects a growing concern and urgency within the biomedical community.

Declining or Waning

While the Journal of Biomedical Science has a robust focus on a variety of topics, certain areas have seen a noticeable decline in publication frequency, reflecting shifting research interests and priorities in the biomedical field.
  1. Traditional Laboratory Techniques:
    There has been a reduced emphasis on conventional laboratory techniques and methodologies, as the field increasingly shifts towards automation and advanced technologies.
  2. Basic Science without Clinical Relevance:
    Papers that focus solely on basic biological science without direct clinical applications have become less common, as the journal prioritizes translational research that bridges laboratory findings with clinical practice.
  3. Non-Communicable Diseases:
    Research on non-communicable diseases, particularly in niche areas with limited clinical implications, appears to be less frequently represented in recent issues.

Similar Journals

Clinical Laboratory

Innovating Insights in Laboratory Medicine
Publisher: CLIN LAB PUBLISSN: 1433-6510Frequency: 12 issues/year

Clinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.

Cell Reports Medicine

Advancing biomedical knowledge for a healthier tomorrow.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Acta Naturae

Driving Innovation in Life Sciences Research
Publisher: RUSSIAN FEDERATION AGENCY SCIENCE & INNOVATIONISSN: 2075-8251Frequency: 4 issues/year

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

Biomedical Research and Therapy

Elevating therapeutic breakthroughs with rigorous insights.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Immuno

Advancing Immunology Through Open Access Innovation
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

MOLECULAR ASPECTS OF MEDICINE

Transforming Insights into Molecular Health Solutions
Publisher: ELSEVIERISSN: 0098-2997Frequency: 6 issues/year

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

Revista Romana de Medicina de Laborator

Empowering Knowledge in Laboratory Practices
Publisher: SCIENDOISSN: 1841-6624Frequency: 4 issues/year

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

JOURNAL OF MOLECULAR MEDICINE-JMM

Unveiling the Molecular Mysteries of Health and Disease.
Publisher: SPRINGER HEIDELBERGISSN: 0946-2716Frequency: 12 issues/year

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

Byulleten Sibirskoy Meditsiny

Bridging Research and Clinical Practice in Molecular Medicine
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Biomedical Reports

Bridging gaps in pharmacology and neuroscience.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.